Drug Manufacturers - General · NYSE
Precio Actual
$1008.27
VENTAJA COMPETITIVA
↑Patent Protection on Key Drugs
Lilly benefits from strong patent protection on drugs like Trulicity and Mounjaro. This exclusivity allows for premium pricing and market share dominance before generics enter.
↑Established Brand Reputation in Diabetes Care
Lilly has cultivated a strong brand in diabetes, fostering physician and patient loyalty. This reputation provides a competitive edge in a growing market.
↑Pipeline of Innovative Therapies
Lilly's robust pipeline, particularly in Alzheimer's and obesity, offers future growth potential. Successful drug launches will further solidify their market position.
RIESGOS DE INVERSIÓN
↓Patent Expirations and Generic Competition
Loss of exclusivity on key drugs will significantly impact revenue. Lilly must successfully launch new products to offset these losses and maintain growth.
↓Clinical Trial Failures and Regulatory Hurdles
Drug development is inherently risky, and clinical trial failures are common. Regulatory delays or rejections can significantly impact pipeline value.
↓Pricing Pressure and Reimbursement Challenges
Increasing pressure from payers to lower drug prices could erode profitability. Changes in reimbursement policies could limit access to Lilly's therapies.
Combina los insights de IA con la valoración DCF o PE para calcular el valor intrínseco. Toma mejores decisiones de valoración con datos.
Esta página proporciona insights de valoración con IA para Eli Lilly and Company (LLY), incluyendo ventaja competitiva y factores de riesgo de inversión. La valoración es central para decisiones de inversión sólidas — usa las herramientas de valoración DCF y PE de MiniValuator junto con estos insights de IA para calcular el valor intrínseco de LLY, el margen de seguridad, y llegar a una valoración bien fundamentada.
